The Vice Presidents at Proteovant Therapeutics lead their respective departments—Biology, Discovery Chemistry, CMC (Chemistry, Manufacturing, and Controls), DMPK (Drug Metabolism and Pharmacokinetics), Molecular Technology, and Program Management. They ensure strategic alignment and operational excellence in their fields, driving the development of innovative protein degradation therapies for disease treatment.
View all